<DOC>
	<DOCNO>NCT00384072</DOCNO>
	<brief_summary>The purpose study evaluate effect 20 mg bazedoxifene comparison placebo bone mineral density 6 month therapy population postmenopausal Asian woman .</brief_summary>
	<brief_title>Study Evaluating Safety Efficacy Bazedoxifene Postmenopausal Asian Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>1 . Generally healthy Asian woman 45 year age old least 1 year postmenopausal 2 . Subjects must qualify one follow category ( b ) : 1 . Greater 1 year less 5 year postmenopausal least one ospeoporosis risk factor 2 . Equal great 5 year postmenopausal BMD Tscore lumbar spine femoral neck 1 2.5 ( value 1 2.5 acceptable ) least one osteoporosis risk factor 1 . One ( 1 ) osteoporotic vertebral fracture ( T4 L4 ) 2 . BMD Tscore lumbar spine femoral neck le 2.5 3 . Past history active nontraumatic venous thromboembolic event , include deep vein thrombosis , pulmonary embolism , retinal vein thrombosis</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>postmenopausal</keyword>
	<keyword>woman</keyword>
	<keyword>SERM</keyword>
	<keyword>osteoporosis</keyword>
</DOC>